CNMD
CONMED
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: CNMD
- PE Ratio
As of Aug 21, 2026, the CONMED stock's P/E ratio is 27.61. This takes into account the latest EPS of $1.85 and stock price of $51.07. The PE ratio has increased by 27% from its last 4 quarters average of 21.8.
CNMD PE ratio history
The PE ratio of CONMED has averaged 238.3 over the last ten years. The current price-to-earnings ratio of 27.61 is 88% less than the historical average. Analyzing the last ten years, CNMD's PE ratio reached its highest point in the Sep 2020 quarter at 3,933.5, when the price was $78.67 and the EPS was $0.02. The lowest point was recorded in the Jun 2025 quarter, when it reached 14.63 with a price of $52.08 and an EPS of $3.56.
CONMED PE ratio by year
Maximum annual increase: 3,332.29% in 2011
Maximum annual decrease: -97.72% in 2012
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 26.71 | 67.46% | $40.6 | $1.52 |
| 2024 | 15.95 | -69.42% | $68.44 | $4.29 |
| 2023 | 52.15 | N/A | $109.51 | $2.1 |
| 2022 | N/A | N/A | $88.64 | -$2.68 |
| 2021 | 66.24 | -80.48% | $141.76 | $2.14 |
| 2020 | 339.39 | 206.53% | $112 | $0.33 |
| 2019 | 110.72 | 150.05% | $111.83 | $1.01 |
| 2018 | 44.28 | 72.9% | $64.2 | $1.45 |
| 2017 | 25.61 | -69.27% | $50.97 | $1.99 |
| 2016 | 83.34 | 108.09% | $44.17 | $0.53 |
| 2015 | 40.05 | 4.22% | $44.05 | $1.1 |
| 2014 | 38.43 | 17.56% | $44.96 | $1.17 |
| 2013 | 32.69 | 67.21% | $42.5 | $1.3 |
| 2012 | 19.55 | -97.72% | $27.95 | $1.43 |
| 2011 | 855.67 | 3,332.29% | $25.67 | $0.03 |
CONMED PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2026 | 17.69 | -11.46% | $32.73 | $1.85 |
| Mar 2026 | 19.98 | -25.2% | $35.36 | $1.77 |
| Dec 2025 | 26.71 | 17% | $40.6 | $1.52 |
| Sep 2025 | 22.83 | 56.05% | $47.03 | $2.06 |
| Jun 2025 | 14.63 | -6.99% | $52.08 | $3.56 |
| Mar 2025 | 15.73 | -1.38% | $60.39 | $3.84 |
| Dec 2024 | 15.95 | -5.06% | $68.44 | $4.29 |
| Sep 2024 | 16.8 | -22.22% | $71.92 | $4.28 |
| Jun 2024 | 21.6 | -27.44% | $69.32 | $3.21 |
| Mar 2024 | 29.77 | -42.91% | $80.08 | $2.69 |
| Dec 2023 | 52.15 | 0.33% | $109.51 | $2.1 |
| Sep 2023 | 51.98 | 12.07% | $100.85 | $1.94 |
| Jun 2023 | 46.38 | N/A | $135.89 | $2.93 |
| Mar 2023 | N/A | N/A | $103.86 | -$3.17 |
| Dec 2022 | N/A | N/A | $88.64 | -$2.68 |
CNMD Price vs fair value
CNMD average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
CNMD's current PE ratio is higher than the 3-year average, but it is under its 5 and 10-year averages.
PE comparison
With a price to earnings (P/E) of 27.61, CNMD stands higher than the Healthcare sector and its peers average but lower than the industry average. Looking at the Healthcare sector average of 24.52, CONMED's price to earnings (P/E) is 13% higher.
CNMD PE vs peers
Frequently asked questions
What is CONMED's PE ratio?
CNMD's price to earnings ratio is 27.61 as of Aug 21, 2026.
What is the 3-year average PE ratio for CONMED (CNMD)?
As an average over the last 3 years, CNMD stock has a PE ratio of 25.49.
What is the 5-year average PE ratio for CONMED (CNMD)?
As an average over the last 5 years, CNMD stock has a PE ratio of 33.98.
What is the highest PE ratio for CNMD?
Over the last ten years, the Sep 2020 quarter recorded the highest quarterly PE ratio at 3,933.5.
How does the current PE ratio for CNMD compare to its historical average?
CNMD's price to earnings ratio is currently 88% below its 10-year historical average.
How is CNMD's PE ratio calculated (CONMED PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Aug 21, 2026), CONMED's share price is $51.07. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2026 is $1.85. Therefore, CONMED's price to earnings ratio for today is 27.61. PE RATIO(27.61) = STOCK PRICE($51.07) / TTM EPS($1.85)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.